Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression

Title
Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression
Authors
Keywords
Cutaneous melanoma, Vemurafenib, BRAF inhibitor, Treatment beyond progression, Overall survival
Journal
EUROPEAN JOURNAL OF CANCER
Volume 51, Issue 5, Pages 642-652
Publisher
Elsevier BV
Online
2015-02-15
DOI
10.1016/j.ejca.2015.01.009

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started